anti-CCR8 monoclonal antibody CM369
Term · Oncology and biomedicine · MLC-T-ONC-010206
A monoclonal antibody against C-C-chemokine receptor 8 (CCR8), with potential immunomodulating and antineoplastic activities. Upon administration, anti-CCR8 monoclonal antibody CM369 targets and binds to CCR8 on CCR8-positive tumor-infiltrating regulatory T cells (Tregs) in the tumor microenvironment (TME), and depletes CCR8-positive tumor-infiltrating Tregs via antibody-dependent cellular cytotoxicity (ADCC). This may reactivate antitumor immune responses. CCR8 is specifically expressed by tumor-infiltrating Tregs in multiple types of cancer and plays a key role in immunosuppression.
| Identifier | MLC-T-ONC-010206 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-CCR8 monoclonal antibody ICP-B05 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010206",
"term": "anti-CCR8 monoclonal antibody CM369",
"field": "Oncology and biomedicine",
"definition": "A monoclonal antibody against C-C-chemokine receptor 8 (CCR8), with potential immunomodulating and antineoplastic activities. Upon administration, anti-CCR8 monoclonal antibody CM369 targets and binds to CCR8 on CCR8-positive tumor-infiltrating regulatory T cells (Tregs) in the tumor microenvironment (TME), and depletes CCR8-positive tumor-infiltrating Tregs via antibody-dependent cellular cytotoxicity (ADCC). This may reactivate antitumor immune responses. CCR8 is specifically expressed by tumor-infiltrating Tregs in multiple types of cancer and plays a key role in immunosuppression.",
"synonyms": [
"anti-CCR8 monoclonal antibody ICP-B05"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-ccr8-monoclonal-antibody-cm369/"
}
Record 1,291 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.